About Tonix Pharma
Tonix Pharma is a company based in New York (United States) founded in 2007.. Tonix Pharma has raised $4.45 million across 10 funding rounds from investors including NIH and Technology Partners. The company has 81 employees as of December 31, 2024. Tonix Pharma offers products and services including TNX-102 SL, TNX-1300, TNX-1500, TNX-801, and TNX-1800. Tonix Pharma operates in a competitive market with competitors including CareDx, PanTher Therapeutics, BioAge Labs, Eledon and Onconic Therapeutics, among others.
- Headquarter New York, United States
- Employees 81 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Tonix Pharmaceuticals Holding Corp.
-
Annual Revenue
$10.09 M29.94as on Dec 31, 2024
-
Net Profit
$-130.04 M-11.47as on Dec 31, 2024
-
EBITDA
$-74.32 M34.86as on Dec 31, 2024
-
Total Equity Funding
$4.45 M (USD)
in 10 rounds
-
Latest Funding Round
$15 M (USD), Post-IPO
Oct 25, 2022
-
Investors
NIH
& 1 more
-
Employee Count
81
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Tonix Pharma
Tonix Pharma is a publicly listed company on the NASDAQ with ticker symbol TNXP in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Tonix Pharma
Tonix Pharma offers a comprehensive portfolio of products and services, including TNX-102 SL, TNX-1300, TNX-1500, TNX-801, and TNX-1800. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for fibromyalgia and related disorders.
Therapy for cocaine intoxication and overdose.
Antibody for organ transplant rejection.
Vaccine candidate for mpox and smallpox.
Vaccine for COVID-19 and related viruses.
Treatment for Prader-Willi syndrome.
Unlock access to complete
Unlock access to complete
Funding Insights of Tonix Pharma
Tonix Pharma has successfully raised a total of $4.45M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $15 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $15.0M
-
First Round
First Round
(17 Aug 2010)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Post-IPO - Tonix Pharma | Valuation |
investors |
|
| Aug, 2022 | Amount | Grant - Tonix Pharma | Valuation |
investors |
|
| Jun, 2022 | Amount | Post-IPO - Tonix Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tonix Pharma
Tonix Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH and Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in US life sciences and energy companies.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tonix Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tonix Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tonix Pharma Comparisons
Competitors of Tonix Pharma
Tonix Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CareDx, PanTher Therapeutics, BioAge Labs, Eledon and Onconic Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical solutions for transplant patients are developed and provided.
|
|
| domain | founded_year | HQ Location |
Drug delivery systems for inoperable solid tumors are developed.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| domain | founded_year | HQ Location |
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and gastrointestinal diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tonix Pharma
Frequently Asked Questions about Tonix Pharma
When was Tonix Pharma founded?
Tonix Pharma was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Where is Tonix Pharma located?
Tonix Pharma is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Tonix Pharma a funded company?
Tonix Pharma is a funded company, having raised a total of $4.45M across 10 funding rounds to date. The company's 1st funding round was a Post-IPO of $30M, raised on Aug 17, 2010.
How many employees does Tonix Pharma have?
As of Dec 31, 2024, the latest employee count at Tonix Pharma is 81.
What is the annual revenue of Tonix Pharma?
Annual revenue of Tonix Pharma is $10.09M as on Dec 31, 2024.
What does Tonix Pharma do?
Tonix Pharma was founded in 2007 and is headquartered in New York, United States. Medicines targeting central nervous system and immunological disorders are developed by the company within the pharmaceutical sector. Operations focus on advancing therapeutic candidates, including TNX-601 (tianeptine oxalate) for post-traumatic stress disorder treatment and TNX-801 involving horsepox virus. Research and development activities are conducted to address unmet medical needs in these areas.
Who are the top competitors of Tonix Pharma?
Tonix Pharma's top competitors include CareDx, PanTher Therapeutics and BioAge Labs.
What products or services does Tonix Pharma offer?
Tonix Pharma offers TNX-102 SL, TNX-1300, TNX-1500, TNX-801, and 2 more products and services.
Is Tonix Pharma publicly traded?
Yes, Tonix Pharma is publicly traded on NASDAQ under the ticker symbol TNXP.
Who are Tonix Pharma's investors?
Tonix Pharma has 2 investors. Key investors include NIH, and Technology Partners.
What is Tonix Pharma's ticker symbol?
The ticker symbol of Tonix Pharma is TNXP on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.